GlassScriptPhysician profile
Samaaneh Moezzi
NPI 1093328387
$1,478.58
in general payments reported to CMS, 2019-2025
10 companies · $236 in 2025
The $236 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $314 · 2022: $268 · 2023: $212 · 2024: $448 · 2025: $236.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $896.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $896.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $354.94 | 2024-2025 | Caplyta |
| Abbvie INC. | $341.02 | 2021-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $268.44 | 2021-2022 | |
| Supernus Pharmaceuticals, INC. | $171.92 | 2023-2024 | Qelbree, Qelbree |
| Sunovion Pharmaceuticals INC. | $136.25 | 2021-2022 | |
| Otsuka America Pharmaceutical, INC. | $71.29 | 2022 | |
| Neurocrine Biosciences, INC. | $58.88 | 2024 | Ingrezza |
| Lundbeck LLC | $34.66 | 2022-2023 | Rexulti |
| Neos Therapeutics, LP | $26.76 | 2023 | Adzenys Xr-Odt |
| Janssen Pharmaceuticals, INC | $14.42 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samaaneh Moezzi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.